Gain Therapeutics Inc (GANX)
NASDAQ
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -664.545 | -69.7 | -57.05 | -55.77 | -103.536 |
Return on Equity (%) | 974.667 | -124.374 | -67.577 | -65.518 | -140.562 |
Return on Invested Capital (%) | 914.009 | -108.998 | -65.383 | -67.762 | -145.776 |
Operating Margin (%) | -5280.488 | -12317.241 | -8397.576 | -12498.571 | -40341.818 |
Net Profit Margin (%) | -5348.78 | -12334.483 | -8400 | -12565 | -40198.182 |
Book Value Per Share | -0.2 | 1.542 | 2.913 | 1.571 | 0.959 |
Earnings Per Share | -0.975 | -0.889 | -1.166 | -1.48 | -1.713 |
Cash Per Share | 0.135 | 1.863 | 3.104 | 0.613 | 0.914 |
Working Capital Per Share | -0.2 | 1.708 | 2.96 | 1.428 | 0.994 |
Operating Profit Per Share | 0.018 | 0.007 | 0.016 | 0.012 | 0.004 |
EBIT Per Share | -0.972 | -0.888 | -1.166 | -1.473 | -1.719 |
EBITDA Per Share | -0.972 | -0.888 | -1.166 | -1.473 | -1.719 |
Free Cash Flow Per Share | -0.97 | -0.886 | -1.16 | -1.476 | -1.718 |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 2.25M | 4.02M | 11.88M | 11.88M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Shares Outstanding | 11.88M | 11.88M | N/A | 12.63M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -9309.091 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -9340 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 44.56M |
Price to Earnings Ratio | -2.13 |
Price to Sales Ratio | 836.36 |
Price to Cash Ratio | 3.98 |
Price to Book Ratio | 3.74 |
Dividend Yield | - |
Shares Outstanding | 25.54M |
Average Volume (1 week) | 241.69k |
Average Volume (1 Month) | 280.42k |
52 Week Change | -32.42% |
52 Week High | 5.33 |
52 Week Low | 0.89 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.